Feature Story
Reduced prostate screening could miss advanced tumors
THURSDAY, September 24, 2015 (CBS News) — Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests.
In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then, PSA screening has dropped by 28 percent, the researchers report.
You might have also missed…
Sandra Lee is back, says she’s ‘cancer-free’ Sept 22, USA Today This article includes a tweet from the Prevent Cancer Foundation!
“Early detection:” Woman diagnosed with lung cancer says preventative procedure likely saved her life Sept 23, Fox Now
Colorectal Cancer Sept 23, Williamson Daily News
What to know before getting the genetic test for breast cancer Sept 24, Chicago Tribune
